Liquidia Corporation (LQDA) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 01/15/26
Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be IgnoredSeeking Alpha • 01/08/26
Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in FocusZacks Investment Research • 12/15/25
Wall Street Analysts See a 51.15% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?Zacks Investment Research • 11/24/25
Liquidia Corporation (LQDA) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/19/25
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug LaunchThe Motley Fool • 11/17/25
Wall Street Analysts Think Liquidia Corporation (LQDA) Could Surge 62.34%: Read This Before Placing a BetZacks Investment Research • 11/06/25
Liquidia Corporation to Present at Upcoming Healthcare Investment ConferencesGlobeNewsWire • 11/03/25
Liquidia Corporation (LQDA) Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies TranscriptSeeking Alpha • 10/29/25
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025GlobeNewsWire • 10/27/25
Wall Street Analysts Believe LIQUIDIA CORP (LQDA) Could Rally 50.94%: Here's is How to TradeZacks Investment Research • 10/21/25
Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare ConferenceGlobeNewsWire • 08/27/25
Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research • 08/12/25
Liquidia Shoots Higher, But At-Risk Launch Could Come Back To Haunt ItInvestors Business Daily • 08/12/25
Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/12/25